P273 EZETIMIBE/SIMVASTATIN 10/20 mg VERSUS ROSUVASTATIN 10...

Atherosclerosis Supplements 2010 / 6 Vol. 11; Iss. 2

P273 EZETIMIBE/SIMVASTATIN 10/20 mg VERSUS ROSUVASTATIN 10 mg IN HIGH RISK HYPERCHOLESTEROLEMIC PATIENTS STRATIFIED BY PRIOR STATIN TREATMENT POTENCY

Viigimaa, M., Vaverkova, H., Farnier, M., Averna, M., Missault, L., Dong, Q., Shah, A., Hanson, M., Brudi, P.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
11
Language:
english
Journal:
Atherosclerosis Supplements
DOI:
10.1016/s1567-5688(10)70340-8
Date:
June, 2010
File:
PDF, 48 KB
english, 2010
Conversion to is in progress
Conversion to is failed